Log in

Application of Solid-Phase Extraction for the Quantification of Urinary AICAR by Ultra-High Performance Liquid Chromatography–Tandem Mass-Spectrometry

  • ARTICLES
  • Published:
Journal of Analytical Chemistry Aims and scope Submit manuscript

Abstract

A procedure for the determination of AICAR (5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside, Acadesine), an AMP-activated protein kinase agonist prohibited by the World Anti-Do** Agency since 2009, in urine has been proposed including sample clean-up from matrix components by means of solid-phase extraction and detection of the analyte by ultra-high performance liquid chromatography–tandem mass-spectrometry with heated electrospray ionization ion source. Due to the endogenous nature of AICAR, standard additions approach was applied to quantify AICAR and evaluate matrix effects. The limit of detection was 5 ng/mL, calibration curves were linear in the concentration range of 50–5000 ng/mL. The proposed procedure was applied to the analysis of real samples.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price includes VAT (Germany)

Instant access to the full article PDF.

Fig. 1.

Similar content being viewed by others

REFERENCES

  1. Loef, B., de Hollander, E.L., Boot, C.R.L., and Proper, K.I., Prev. Med. Rep., 2016, vol. 3, p. 30.

    Article  PubMed  Google Scholar 

  2. Li, S. and Laher, I., Trends Pharmacol. Sci., 2015, vol. 36, no. 12, p. 906.

    Article  CAS  PubMed  Google Scholar 

  3. Narkar, V.A., Downes, M., Yu, R.T., Embler, E., Wang, Y.X., Banayo, E., Mihaylova, M.M., Nelson, M.C., Zou, Y., Juguilon, H., Kang, H., Shaw, R.J., and Evans, R.M., Cell, 2008, vol. 134, no. 3, p. 405.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Towler, M.C. and Hardie, D.G., Circ. Res., 2007, vol. 100, no. 3, p. 328.

    Article  CAS  PubMed  Google Scholar 

  5. Pokrywka, A., Cholbinski, P., Kaliszewski, P., Kowalczyk, K., Konczak, D., and Zembron-Lacny, A., J. Physiol. Pharmacol., 2014, vol. 65, no. 4, p. 469.

    CAS  PubMed  Google Scholar 

  6. Musi, N. and Goodyear, L.J., Curr. Drug Targets: Immune, Endocr. Metab. Disord., 2002, vol. 2, no. 2, p. 119.

    CAS  Google Scholar 

  7. Viollet, B., Mounier, R., Leclerc, J., Yazigi, A., Foretz, M., and Andreelli, F., Diabetes Metab., 2007, vol. 33, no. 6, p. 395.

    Article  CAS  PubMed  Google Scholar 

  8. Hardie, D.G., Ross, F.A., and Hawley, S.A., Nat. Rev. Mol. Cell. Biol., 2012, vol. 13, no. 4, p. 251.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. The 2018 Prohibited List, the World Anti-Do** Code, International Standard, 2018. www.wada-ama.org/sites/default/files/prohibited_list_2018_en.pdf. Accessed April 4, 2018.

  10. Guddat, S., Solymos, E., Orlovius, A., Thomas, A., Sigmund, G., Geyer, H., Thevis, M., and Schänzer, W., Drug Test. Anal., 2011, vol. 3, nos. 11–12, p. 836.

    Article  CAS  PubMed  Google Scholar 

  11. Thomas, A., Beuck, S., Eickhoff, J.C., Guddat, S., Krug, O., Kamber, M., Schänzer, W., and Thevis, M., Anal. Bioanal. Chem., 2010, vol. 396, no. 8, p. 2899.

    Article  CAS  PubMed  Google Scholar 

  12. Kwok, W.H., Choi, T.L.S., Kwok, K.Y., Chan, G.H.M., Wong, J.K.Y., and Wan, T.S.M., J. Chromatogr. A, 2016, vol. 1451, p. 41.

    Article  CAS  PubMed  Google Scholar 

  13. Wong, J.K.Y., Kwok, W.H., Chan, G.H.M., Choi, T.L.S., Ho, E.N.M., Jaubert, M., Bailly-Chouriberry, L., Bonnaire, Y., Cawley, A., Ming Williams, H., Keledjian, J., Brooks, L., Chambers, A., Lin, Y., and Wan, T.S.M., Drug Test. Anal., 2017, vol. 9, no. 9, p. 1363.

    Article  CAS  PubMed  Google Scholar 

  14. Gorgens, C., Guddat, S., Orlovius, A.K., Sigmund, G., Thomas, A., Thevis, M., and Schänzer, W., Anal. Bioanal. Chem., 2015, vol. 407, no. 18, p. 5365.

    Article  CAS  PubMed  Google Scholar 

  15. Minimum Criteria for Chromatographic–Mass Spectrometric Confirmation of the Identity of Analytes for Do** Control Purposes, WADA Technical Document TD2015IDCR, 2015. www.wada-ama.org/ sites/default/files/resources/files/td2015idcr_-_eng.pdf. Accessed April 4, 2018.

  16. Buisson, C., Frelat, C., Mongongu, C., Martinat, N., and Audran, M., Drug Test. Anal., 2017, vol. 9, nos. 11–12, p. 1704.

    Article  CAS  PubMed  Google Scholar 

  17. Piper, T., Thomas, A., Baume, N., Sobolevsky, T., Saugy, M., Rodchenkov, G., Schänzer, W., and Thevis, M., Rapid Commun. Mass Spectrom., 2014, vol. 28, no. 11, p. 1194.

    Article  CAS  PubMed  Google Scholar 

  18. FDA Guidance for Industry: Bioanalytical Method Validation, Rockville: US Department of Health and Human Services, Food and Drug Administration (FDA), 2018. www.fda.gov/downloads/drugs/guidances/ ucm070107.Pdf. Accessed September 27, 2018.

Download references

FUNDING

The studies were conducted as part of the Project no. 4.2612.2017/PC by the Ministry of Education and Science of the Russian Federation and supported by the Russian Foundation for Basic Research, project no. 18-33-20009 mol_a_ved, using scientific equipment of Ecological Analytical Core Facility Center of the Kuban State University, unique identifier RFMEFI59317Х0008.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to E. V. Dmitrieva.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dmitrieva, E.V., Temerdashev, A.Z., Azaryan, A.A. et al. Application of Solid-Phase Extraction for the Quantification of Urinary AICAR by Ultra-High Performance Liquid Chromatography–Tandem Mass-Spectrometry. J Anal Chem 74, 861–864 (2019). https://doi.org/10.1134/S1061934819090041

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1134/S1061934819090041

Keywords:

Navigation